Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Opportunities and challenges for human papillomavirus vaccination in cancer
Richard B.S. Roden, Peter L. Stern
Nature reviews. Cancer (2018) Vol. 18, Iss. 4, pp. 240-254
Open Access | Times Cited: 288

Showing 1-25 of 288 citing articles:

Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth, Kathrin U. Jansen
npj Vaccines (2019) Vol. 4, Iss. 1
Open Access | Times Cited: 608
Human papillomaviruses: diversity, infection and host interactions
Alison A. McBride
Nature Reviews Microbiology (2021) Vol. 20, Iss. 2, pp. 95-108
Closed Access | Times Cited: 247
Human Papillomavirus Vaccines: An Updated Review
Liqin Cheng, Yan Wang, Juan Du
Vaccines (2020) Vol. 8, Iss. 3, pp. 391-391
Open Access | Times Cited: 223
HPV post-infection microenvironment and cervical cancer
Yi Yuan, Xushan Cai, Fangrong Shen, et al.
Cancer Letters (2020) Vol. 497, pp. 243-254
Closed Access | Times Cited: 168
Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021
Qing Wu, Wei Qian, Xiaoli Sun, et al.
Journal of Hematology & Oncology (2022) Vol. 15, Iss. 1
Open Access | Times Cited: 135
Worldwide trends in cervical cancer incidence and mortality, with predictions for the next 15 years
Shujuan Lin, Kai Gao, Simeng Gu, et al.
Cancer (2021) Vol. 127, Iss. 21, pp. 4030-4039
Open Access | Times Cited: 123
Cancers make their own luck: theories of cancer origins
Amir Jassim, Eric P. Rahrmann, Benjamin D. Simons, et al.
Nature reviews. Cancer (2023) Vol. 23, Iss. 10, pp. 710-724
Open Access | Times Cited: 115
Identification of host–pathogen-disease relationships using a scalable multiplex serology platform in UK Biobank
Alexander J. Mentzer, Nicole Brenner, Naomi E. Allen, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 72
Updates on HPV Vaccination
Ojone Illah, Adeola Olaitan
Diagnostics (2023) Vol. 13, Iss. 2, pp. 243-243
Open Access | Times Cited: 60
Human papillomavirus genomics: Understanding carcinogenicity
Chase W. Nelson, Lisa Mirabello
Tumour Virus Research (2023) Vol. 15, pp. 200258-200258
Open Access | Times Cited: 58
Glioblastoma vaccines: past, present, and opportunities
Zujian Xiong, Itay Raphael, Michael R. Olin, et al.
EBioMedicine (2024) Vol. 100, pp. 104963-104963
Open Access | Times Cited: 28
Dendritic-cell-targeting virus-like particles as potent mRNA vaccine carriers
Di Yin, Yiye Zhong, Sikai Ling, et al.
Nature Biomedical Engineering (2024)
Closed Access | Times Cited: 25
Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics
Jonas Michel Wolf, Lucas Felipe Kist, Samanta Brangel Pereira, et al.
Reviews in Medical Virology (2024) Vol. 34, Iss. 3
Open Access | Times Cited: 24
Oral manifestations of human papillomavirus infections
Stina Syrjänen
European Journal Of Oral Sciences (2018) Vol. 126, Iss. S1, pp. 49-66
Open Access | Times Cited: 149
Trial watch: Peptide-based vaccines in anticancer therapy
Lucillia Bezu, Oliver Kepp, Giulia Cerrato, et al.
OncoImmunology (2018) Vol. 7, Iss. 12, pp. e1511506-e1511506
Open Access | Times Cited: 144
Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy
Diogo Estêvão, Natália R. Costa, Rui M. Gil da Costa, et al.
Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms (2019) Vol. 1862, Iss. 2, pp. 153-162
Closed Access | Times Cited: 118
TCR Repertoire as a Novel Indicator for Immune Monitoring and Prognosis Assessment of Patients With Cervical Cancer
Jin-Huan Cui, Kai-Rong Lin, Song-Hua Yuan, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 112
Listeria monocytogenes as a Vector for Cancer Immunotherapy: Current Understanding and Progress
John C. Flickinger, Ulrich Rodeck, Adam E. Snook
Vaccines (2018) Vol. 6, Iss. 3, pp. 48-48
Open Access | Times Cited: 107
Peptides, Antibodies, Peptide Antibodies and More
Nicole Hartwig Trier, Per Brinch Hansen, Gunnar Houen
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 24, pp. 6289-6289
Open Access | Times Cited: 107
Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis
Dongxue Su, Shuai Ma, Lin Shan, et al.
Journal of Clinical Investigation (2018) Vol. 128, Iss. 10, pp. 4280-4296
Open Access | Times Cited: 95
Multidimensional social and cultural norms influencing HPV vaccine hesitancy in Asia
Li Ping Wong, Pooi‐Fong Wong, Megat Mohamad Amirul Amzar Megat Hashim, et al.
Human Vaccines & Immunotherapeutics (2020) Vol. 16, Iss. 7, pp. 1611-1622
Open Access | Times Cited: 73
Tumor Immunity and Immunotherapy for HPV-Related Cancers
A. Shamseddine, Bharat Burman, Nancy Y. Lee, et al.
Cancer Discovery (2021) Vol. 11, Iss. 8, pp. 1896-1912
Open Access | Times Cited: 69
Use of Protamine in Nanopharmaceuticals—A Review
Ivana Ruseska, Katja Fresacher, Christina Petschacher, et al.
Nanomaterials (2021) Vol. 11, Iss. 6, pp. 1508-1508
Open Access | Times Cited: 60
P22 virus-like particles as an effective antigen delivery nanoplatform for cancer immunotherapy
Wenjing Li, Zhe Jing, Shuqing Wang, et al.
Biomaterials (2021) Vol. 271, pp. 120726-120726
Closed Access | Times Cited: 58
HPV Vaccination after Primary Treatment of HPV-Related Disease across Different Organ Sites: A Multidisciplinary Comprehensive Review and Meta-Analysis
Violante Di Donato, Giuseppe Caruso, Giorgio Bogani, et al.
Vaccines (2022) Vol. 10, Iss. 2, pp. 239-239
Open Access | Times Cited: 51
Page 1 - Next Page

Scroll to top